Funding news
VIOLET Pharmaceuticals logo

VIOLET Pharmaceuticals Raises $88

Recently funded · $880.0K UnknownHospitals and Health CareESView source

Get the full VIOLET Pharmaceuticals company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A preclinical biopharma company focused on making metastatic cancer cells more vulnerable to existing treatments has secured $880K in new capital. VIOLET Pharmaceuticals is developing a First-in-Class mRNA nanotherapy designed to directly modulate the Antigen Presentation Machinery (APM) in tumor cells, a mechanism currently unaddressed by specific therapies on the market.

This patented technology aims to improve the efficiency and expand the approved indications of immunotherapies, such as Immune Checkpoint Inhibitors. Backed by science published in leading journals, VIOLET's mRNA nanotherapy has demonstrated radical complete responses in breast cancer tumor and metastasis models when combined with these existing treatments.

Other Spain companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Vegvisir logo

Vegvisir

Estonia

$700.0K
2
Cosm Medical logo

Cosm Medical

Canada

$2.4M
3
Norcod AS logo

Norcod AS

Norway

$4.3M
4
Ecopliant Environmental, Inc. logo

Ecopliant Environmental, Inc.

United States

$550.0K
5
Nexio logo

Nexio

United States

$907.5K